AI assistant
Sending…
RESMED INC — Director's Dealing 2018
Nov 20, 2018
30071_dirs_2018-11-20_86fa97b5-0d2c-40b5-b7a3-852f21989217.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-11-16
Reporting Person: Farrell Michael J. (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-16 | ResMed Common Stock | A | 13640 | — | Acquired | 13640 | Indirect |
| 2018-11-16 | ResMed Common Stock | G | 3300 | — | Disposed | 10340 | Indirect |
| 2018-11-16 | ResMed Common Stock | G | 3300 | — | Acquired | 3300 | Indirect |
| 2018-11-16 | ResMed Common Stock | S | 3300 | $104.49 | Disposed | 0 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 240487 | Direct |
Footnotes
F1: Acquisition originates from a maturity distribution of the Charitable Income Trust II to beneficiaries.
F2: Represents a gift to the Lisette and Michael Farrell Family Foundation, a 501(c)(3) non-profit corporation.
F3: Mr. and Mrs. Farrell retain dispositive power over foundation holdings.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29